选择性地省略腋窝分期:乳腺癌治疗中Choosing Wisely的理由
本文综述了乳腺癌腋窝手术的演变,指出前哨淋巴结活检已取代腋窝淋巴结清扫用于临床淋巴结阴性的浸润性乳腺癌。近期研究表明,对于部分低风险患者,腋窝手术的预后价值极小,应省略前哨淋巴结活检。美国外科肿瘤学会Choosing Wisely指南强调,不应常规对老年早期激素受体阳性乳腺癌患者进行腋窝分期。
要点
- 临床淋巴结阴性的浸润性乳腺癌患者,前哨淋巴结活检已取代腋窝淋巴结清扫。
- 部分低风险患者腋窝手术预后价值极小,可考虑省略前哨淋巴结活检。
- Choosing Wisely指南反对对老年早期激素受体阳性乳腺癌患者常规进行腋窝分期。
核心结论
- 对于部分低风险乳腺癌患者,可安全省略腋窝分期以避免过度治疗。
研究设计与样本
- 本文为综述,基于现有研究及美国外科肿瘤学会Choosing Wisely指南进行论述。
主要发现
- 前哨淋巴结活检已取代腋窝淋巴结清扫用于临床淋巴结阴性的浸润性乳腺癌。
- 近期研究表明,在部分低风险患者中腋窝手术的预后价值极小。
关键数值与推荐
- 美国外科肿瘤学会Choosing Wisely指南推荐:不应常规对老年早期激素受体阳性乳腺癌患者进行腋窝分期。
临床怎么用
- 临床实践中应识别低风险乳腺癌患者,避免不必要的腋窝分期,以减少过度治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Axillary surgery for breast cancer has continually evolved, with sentinel lymph node biopsy for clinically node-negative women with invasive breast cancer having long replaced axillary lymph node dissection. The information obtained from axillary staging has been important in providing prognostic information and guiding adjuvant treatment recommendations. However, recent studies suggest that sentinel lymph node biopsy should be omitted in select low-risk patients whose axillary surgery provides minimal prognostic value. This was highlighted by the Society of Surgical Oncology Choosing Wisely Guidelines, advocating against routine axillary staging in older women with early-stage hormone receptor-positive breast cancer. Since the guideline release, ongoing research has continued to identify the subset of low-risk patients who would benefit from the omission of axillary staging and improve adherence to Choosing Wisely to prevent overtreatment in older people.
引用
- Grossi S, Le J, Armani A, et al. Omitting axillary staging in selected patients: Rationale of Choosing Wisely in breast cancer treatment. Surgery. 2023. PMID: 37169614. doi:10.1016/j.surg.2023.03.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。